can you go off semaglutide cold turkey Stop Taking Rybelsus Turkey? UK Medical Guidance Worried about weight regain after

WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults

In contrast, Novo Nordisk has demonstrated relative resilience, maintaining a steadier share trajectorymoving from 24 per cent in October 2025 to 25 per cent in November 2025, dipping to 23 per cent in December 2025 and 22 per cent in January 2026, before recovering to 25 per cent in both February and March 2026

Lane WS, Weatherall J, Gundgaard J, Pollock RF

Manufacturers change raw material sources, adjust synthesis parameters, or experience personnel turnover that can affect batch quality

These effects typically resolve within the first week as the body adapts

Downing and colleagues, researchers found that nearly a third of all drugs cleared by the FDA pose a safety risk